Fibroblast biology is central to how tissues heal, age, and respond to injury and inflammation. As essential stromal cells, fibroblasts maintain tissue integrity, regulate scarring outcomes, and influence chronic inflammation. Robust, reproducible fibroblast research models are critical for generating clinically relevant data in wound care, dermatology, fibrosis, and regenerative medicine.
Fibroblasts are the principal architects of connective tissue, driving extracellular matrix (ECM) production, wound repair, and tissue remodeling. By controlling collagen, elastin, and fibronectin deposition, they regulate tissue mechanics, cellular signaling, and matrix remodeling dynamics. Dysregulation contributes to chronic non-healing wounds, hypertrophic scars, keloids, pulmonary fibrosis, hepatic fibrosis, scleroderma, and other fibroproliferative diseases impacting healthcare systems worldwide.
Advanced research demands physiologically relevant culture conditions that preserve native fibroblast phenotypes and ECM deposition. Conventional high-serum systems often introduce variability and alter proliferation profiles, limiting predictive outcomes. Low-serum fibroblast culture and ECM-optimized solutions enable more consistent matrix remodeling, balanced fibroblast-keratinocyte interactions, and improved translational development.
CELLnTEC supports fibroblast research with ECM-focused, low-serum (typically 1%) fibroblast media built on advanced basal formulations. Our solutions power high-fidelity 2D fibroblast cultures, advanced 3D full-thickness skin models, and co-cultures with keratinocytes—delivering predictive data for wound healing, scarring, fibrosis, and skin regeneration.
Our dedicated fibroblast portfolio includes primary human dermal fibroblasts, co-culture and 3D full-thickness skin model kits, and optimized media systems. These tools ensure high isolation efficiency, robust proliferation, physiologically relevant ECM production, and balanced co-growth, enabling translational fibroblast models and accelerating therapeutic innovation in regenerative therapies and anti-fibrotic strategies.
By implementing advanced in vitro fibroblast models and 3D skin equivalents, CELLnTEC actively supports the 3R principle—reducing and replacing animal use in research through predictive, human-relevant systems. Our platforms facilitate preclinical evaluation of Advanced Therapy Medicinal Products (ATMPs), including cell and gene therapies, by providing standardized, reproducible microenvironments for safety and efficacy testing in regenerative medicine.
Primary fibroblast cells isolated from the full dermal layer.
Advanced medium formulation supports fibroblasts across tissue types and species.
Designed for early-passage and more mature fibroblast cultures.
Supports clear morphological and structural imaging readouts.
Seamless transition from 2D monolayer cultures to complex 3D skin models.
Characterizing ECM organization and collagen cross-linking dynamics.
Development of in vitro wound healing and scratch-assay fibroblast models.
3D skin equivalents to study barrier repair and tissue remodeling.
Drug screening for anti-fibrotic compounds targeting fibroblast activation.
Investigating fibroblast–immune cell crosstalk in inflammation.
Evaluating biomaterials and wound dressings in fibroblast-seeded constructs.
Assessing fibroblast responses to growth factors or cytokines.
Investigating tumor–stroma interactions with cancer-associated fibroblasts.
1
Air-lift media enabling collagen-free 3D full-thickness model generation with strong fibroblast ECM output.
3
Specialized media designed to drive ECM production for matrix-focused studies.
2
Formulations designed with deep expertise in progenitor cell biology for extended culture while maintaining functional characteristics.
4
Co-culture formulations that remove fibroblast-inhibitory components while supporting balanced cell growth.
Primary epithelial cells growing in CnT-NX-EX display a highly proliferative phenotype. For differentiation experiments, it is recommended to switch to the CnT-PR-D or CnT-PR-3D differentiation media.
